Search for: "United States v. Articles of Food and Drug" Results 41 - 60 of 505
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Aug 2009, 9:46 am
Require yearly registration for domestic facilities and foreign facilities that export to the United States. [read post]
9 Apr 2013, 11:00 am by Michelle Yeary
United States, 335 U.S. 345 (1950) (“One article or thing is accompanied by another when it supplements or explains it . . . [read post]
24 Jun 2013, 10:08 am by Sheppard Mullin
Actavis, Solvay Pharmaceuticals filed a New Drug Application for a brand-name drug called AndroGel.[3] The Federal Food and Drug Administration (“FDA”) approved the application in 2000. [read post]
24 Jun 2013, 6:08 am by Bradley Graveline
On June 17, 2013, the United States Supreme Court announced a rule that blurs the lines between antitrust and patent law in the context of Hatch-Waxman litigation. [read post]
25 Feb 2013, 12:46 pm by Larry
In this case, it comes from the Eleventh Circuit, with a special guest appearance from the Court of International Trade.The case is United States v. [read post]
17 Apr 2012, 1:03 pm
However, as early as 2009, the Food and Drug Administration notified DePuy that it was denying the company’s application to sell the implants domestically. [read post]
28 Sep 2016, 8:39 am by Dennis Crouch
 Mylan asks: “Whether the mere filing of an abbreviated new drug application by a generic pharmaceutical manufacturer is sufficient to subject the manufacturer to specific personal jurisdiction in any state where it might someday market the drug. [read post]
24 Oct 2013, 10:12 am by Mark Zamora
 FDA is not aware of any information demonstrating that aegeline was lawfully marketed as a dietary ingredient in the United States before October 15, 1994, nor is FDA aware of any information demonstrating that this ingredient has been present in the food supply as an article used for food in a form in which the food has not been chemically altered. [read post]
5 Aug 2011, 3:08 pm
However, according to those companies, the Federal Food and Drug Administration regulations for drug labeling preempted state law because the generic drug makers must be the same as the brand name label approved by the FDA. [read post]